Lake Oswego, Oregon-based Biotronik designed Amvia Edge as the market’s smallest single-chamber MR conditional pacemaker. It offers a set of patient-centric solutions coupled with automated workflow efficiency.
The pacemakers feature Biotronik’s proprietary MRI Guard 24/7 technology. It uses always-on, dedicated sensors to automatically recognize a patient’s entrance into an MRI field. The MRI Guard then converts the device to MRI mode and returns to its permanent programming after the scan completes. This eliminates any pre- or post-scan programming needs.
“MRI Guard 24/7 is a solution for real-world challenges, as we strive to improve safety and increase efficiencies for CIED patients who need MRI access,” said Dr. David Hayes, chief medical officer, Biotronik. “An MRI scan should be as easy as possible for patients, but also for caregivers in the device clinic and the MRI suite. MRI Guard 24/7 avoids repeat visits to the clinic for pre- and post-programming, and because the device only switches to MRI mode during the scan itself, it minimizes any potential patient discomfort.”
More about the Biotronik Amvia Edge pacemakers
All Amvia Edge devices also feature Atrial ATP (aATP). This provides multiple automatic therapies in response to detected stable atrial arrhythmias. Biotronik says this may reduce atrial tachycardia burden and help avoid atrial remodeling.
The Amvia Edge pacemakers include new tools that automate key tasks like pre-discharge checks. Biotronik’s EarlyCheck feature automatically sends a device report and IEGM to the Home Monitoring Service Center two hours post-implant. This eliminates the need for in-person device interrogation.
“Amvia Edge represents Biotronik’s continued commitment to healthcare professionals to help them serve their patients,” said Ryan Walters, president, Biotronik. “The clinical treatment options and built-in efficiencies of Amvia are designed to solve everyday challenges for patients, physicians, and caregivers.”
